Member Info for Mozax

An RNS regarding Siemens would have been issued already, had anything changed, it’s material news.

My view is that Invinity have expanded their Vancouver operations to manufacture at scale and this is a separate announcement to the Market as Mistral starts to gain Momentum.

I believe we will get another announcement regarding the launch of Mistral with a pilot with Siemens.

However, whatever the order of announcements, it doesn’t detract from the statement that revenues are going to double this year, double again next year, and double again in 2025, according to the recent podcast.

I’ll certainly not be selling any at this point.

Currently making a loss of £3.6M.

Be careful. Imo.

I’ve been thinking more about Ian Mattioli recently investing £500K into Kanabo & taking the position of Non-executive Chairman.

People should research him and come to their own conclusions about the rationale to invest a relatively large sum in a small Company. He’s a shrewd businessman but cautious too.

The potential market for Medical Cannabis is simply enormous.

KNB has a current MCap of £10M, £2.5M in cash and owns The GP Service, which it paid around £15M for.

The Company has recently launched ‘Treat it’ , an online service aimed at specialist pain treatment.

Telemedicine in itself is growing very quickly, ignoring the fact that KNB, via The GP service, has access to all NHS records.

Furthermore, we have US Patent -pending formula for sleep disorders.

The Company is building some very solid foundations both in medicinal cannabis & digital health services.

That’s interesting, good link spmx.

Not seen a Company where a Director is constantly buying stock on the open market at such a rate, when I spotted he’d had another chunk at 285p I thought, Jeez that’s cheap, I bought here years ago at more than that, and still only 16M shares in issue.

This could move up very quickly when ‘conditions’ allow, put them in the ISA, & switch off.

This is also listed on Aquis plus The OTC in the US, where it’s up 13.96% today.

A lot of stock tightly held so it can move pretty fast.

That is a great interview with Larry, when this starts to move it’s going to keep going, it’s an enormous market and Invinity is miles ahead…….. I’m anticipating a fair bit of newsflow of the next months.

Get these in the ISA and leave them alone!!

This appointment also reinforces the professionalism and commitment to building a serious quality Company.

Ian Mattioli wouldn’t have taken the Position if he wasn’t impressed with the Company, and optimistic about its future.

I suspect the next key announcement will be the European CE approval for the Groups Unique meter dose cannabis inhaler. Approval expected in the 3rd quarter, so anytime from July 2023 onwards.

Interesting that he has come aboard here.

I’ve done some research on his own Company and he is very shrewd.

“We remind readers that acquisitive growth is a core part of MW’s strategy. It has a long track record of success with 34 acquisitions (excluding White) since its admission to AIM in 2005.”

I expect to see KNB grow rapidly through acquisitions now the foundations & technology platform are in place. Very interesting appointment indeed.

Good opportunity to buy at a 35% discount to the recent placing imo.

Yup, L2 shifted, 2v1.

Let’s see where this is at 4pm.

Good link 2phevs.

Was being worked I suspect, now it’s hard to buy 10K.

My view is to sit quietly and accept it’s a hold until winter, and see where gas prices sit then.

Also gives time for further licenses to be announced and IOG to gets its MoJo back.

Yes, it’s certainly a strong signal & very positive that CGNR want exposure to KDR and have taken a 5% stake.

Given the multitudinous opportunities that lie ahead for the Company a result in just one will see a solid rerate here.

Should a significant discovery be made this summer, (and it is this summer that they are sampling now with the license in place, and Covid behind us) then the re-rate could be very very significant.

I note that further Sanctions on Russia are underway, with their Diamond exports being targeted.

I’m awaiting further funds and am hoping the stock stays at current levels to enable a final top up, which will give me a substantial holding, all in my ISA.

Remember too, there’s very little freefloat, so a rise on the right news will be very rapid indeed.

June, July, August. September.

After Covid and all the associated cr*p wouldn’t the announcement of a new Major Diamond discovery in Europe be rather exciting.

I hope so, and for the professor too.

Interesting news this evening.

Surely the bottom will be 5p.

A placing of 31M shares at 5p will ensure that.

I’m of the opinion that this is worth tucking away in the ISA for at least 8 months or so.

A combination of cold winter weather & the ongoing Energy security situation and IOG is well placed to provide a solid revenue stream.

licensing round update soon which may provide further upside in the short term.

Whilst very frustrating for the LTH’s sitting on paper losses, I’m confident that these will turn to profits over time.

Good management & some very experienced personnel on board now.

Convertible Loan at 5p suggests confidence in upside.

There’s no point in giving away chunks of the Company with a JV on speculation of Diamond presence, but being to negotiate with a number of Companies wanting to get in on the announcement of substantial evidence will see very serious upside here.

My view is there is very little downside from this level but, although high risk, the potential rewards could be very substantial.

It’s worth tucking a few away in the ISA just in case the wily old professor does it again. Luck of the Irish and all that.

Just Imagine during those long daylight hours of sampling in Finland this summer KDR surprises the market with a rather spectacular announcement.

I’ve tucked a chunk away just in case.

Small-cap movers: Mirriad catapulted on major Microsoft partnership
07:21 Sat 06 May 2023
William Farrington
View
Bushveld Minerals Limited
AIM:BMN
OTC:BSHVF
ladders on blue background reaching to dart board
Here’s a look at all the movers and shakers on the AIM market this week

Small caps are often prone to dramatic price fluctuations. Such is the nature of securities on the lower end of the value spectrum.

But rarely do we see a surge in value the likes of which AIM-listed Mirriad Advertising PLC (AIM:MIRI, OTCQX:MMDDF) enjoyed this week.

The advertising technology group more than tripled its market capitalisation by the time Friday rolled around (and in fact briefly surged as much as 500% on Thursday), and for good reason.

Announced on Wednesday, Mirriad has been chosen to collaborate with none other than Microsoft to build a new application programming interface (API) for integrating the Microsoft Azure cloud-computing platform and its AI capabilities for various client-driven use cases.

Mirriad’s patented SceneFinder technology is a touch of genius.

Using digital post-production techniques, Mirriad enables companies to insert product placements into existing visual content, all optimised to reach the widest set of eyeballs possible.

Say you want your sauce brand digitally placed on the kitchen table of a morning cooking show, or your telecoms company’s billboard inserted into the background of a televised football match. SceneFinder makes this possible.

Mirriad’s partnership with Microsoft intends to scale and expand these possibilities.

Chief executive Stephan Beringer said that “partnering with Microsoft is an important milestone for the further development of our in-content advertising platform, proposition and business”.

He added: “The wide-ranging agreement with Microsoft can unlock significant benefits and opportunities for both parties as we continue to develop our technical capabilities and scale the creation and delivery of contextually relevant ad experiences in content.”

Judging by the way shares skyrocketed, investors seem to agree.

Sorry Apple, Microsoft is the cool kid again

Is it time for another round of ad wars in Silicon Valley?

Apple Inc's (NASDAQ:AAPL) financial engineering with its eye-watering share buy-back programme, now extended by a further US$90bn, reveals a tech giant that’s running out of ideas, meanwhile, across Silicon Valley its oft-derided old foe Microsoft showed its ambitions at the bleeding edge of big tech.

The Windows firm is closing in on a significant new partnership with AMD, according to a report by Bloomberg, investing in the chip-maker’s Athena project which seeks to deliver a new generation of processors designed to power the much-hyped AI revolution.

It comes just months after Microsoft deftly moved to become the cornerstone investor in ChatGPT developer OpenAI, pouring US$10bn into the bot maker’s coffers.

I agree. Microsoft is a fairly large & established business.
A Company that many would like to strike a collaboration with.
Our 35 patents, & 13 pending must have quite a value.